Novavax research chief Gregory Glenn told Reuters the company will start much larger late-stage clinical trials soon and could potentially glean enough data to obtain regulatory approvals as early as December.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
No thanks I will takes my chances with covid
WJGunning Distraction from miserable failure.
Nothing as reassuring as a rushed vaccine. Wonder how many people will die from it.